ClinicalTrials.Veeva

Menu

Protein Turnover in Healthy and Overuse-diseased Tendon

B

Bispebjerg Hospital

Status

Completed

Conditions

Patella; Tendinitis

Treatments

Other: Cross-sectional comparison between healthy and tendinopathic group
Other: Progressive resistance training

Study type

Interventional

Funder types

Other

Identifiers

NCT05776485
Project 159

Details and patient eligibility

About

The goal of this clinical trial is to examine the regional protein turnover in tendon tissue from patients with chronic patellar tendinopathy and comparing this to healthy controls. Further we will examine the effect of resistance training on protein turnover in healthy individuals.

Enrollment

36 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Physical active men and women
  • Body mass index 18,5 - 30 kg/m2

Inclusion Criteria for the chronic tendinopathy group:

  • Debut of symptom > 90 days prior to inclusion.
  • Subjective activity related pain in patella tendon.
  • Clinical symptoms of patella tendinopathy.
  • Ultrasound verification of at least 1 in three of the following: Enchanced anterior-posterior diameter, increased Doppler signal and/or a hypoechoic area in the diseased part of the tendon.

Exclusion Criteria for all participants:

  • Former knee surgery or injuries to the patella tendon.
  • Local injection of corticosteroids within 12 months.
  • Medication that affects protein synthesis in tendon tissue.
  • Former/current use of anabolic steroids or growth hormone.
  • Smoking
  • Known rheumatoid disease or diabetes.
  • Former participation in trials using deuterated water and 15N tracers.
  • Treatment for patella tendinopathy within 3 months.

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

36 participants in 2 patient groups

Chronic tendinopathy patients
Experimental group
Treatment:
Other: Cross-sectional comparison between healthy and tendinopathic group
Healthy controls
Experimental group
Treatment:
Other: Progressive resistance training
Other: Cross-sectional comparison between healthy and tendinopathic group

Trial contacts and locations

1

Loading...

Central trial contact

Ann Damgaard

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems